John Theurer Cancer Center First in the Country to Evaluate New AI Technology Assessing Aggressiveness of Prostate Cancer Post Surgery
Urologic oncology researchers in the department of Urology at Hackensack Meridian John Theurer Cancer Center (JTCC) at Hackensack University Medical Center — a research partner with Georgetown’s Lombardi Comprehensive Cancer Center, an NCI-designated comprehensive cancer center — received a significant grant to evaluate a new artificial intelligence-based technology from Artera that would enable doctors to better estimate how aggressive a prostate cancer might be after undergoing radical prostatectomy (prostate removal surgery).